Inhibrx Biosciences Inc.
- INBX
- NASDAQ
- Biotechnology
- Biologic Therapeutics
- Protein Engineering
$89.83
Today −0.74%Quote Oct 16, 2026, 08:00 PM UTC
−14.23%over the last month
Max drawdown −23.9%From 1-month high −19.8%3 months +6.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.32B
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$285.00
+217.3% from here
Floor
$86.20
4.0% below price
Where the price sits
5 analysts
Analyst range, low to high
$245.00$325.00
- Price $89.83
- Resistance $90.60
- Consensus $285.00
The price is right under resistance. Analysts' average target sits about 217% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about INBXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
110